Name: Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration
Aims: This study compares a new drug for treatment of Age-related Macular Degeneration (AMD) with a previously approved treatment (Lucentis ®) to see if the new drug is as safe and works as well to preserve vision.
Diagnosis: The “wet” form of AMD in at least one eye, which has not been previously treated.
Principal Investigator: Manvi Maker, MD
IRB Approval Number: EH14-350
Sponsor: Allergan
Contact: Interested patients may contact Mira Shiloach at 847.657.1750 or via email at mshiloach@northshore.org
Open to Enrollment: Yes

Name: Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity 
Aims: This study is being done to find out the best treatment for swelling in the central part of the retina in patients with diabetes. The treatments being studied include an injection of medicine into the eye, a laser eye treatment, and watching the eye to see if vision gets worse and then treating with an injection.
Diagnosis: Diabetic Macular Edema
Principal Investigator: Manvi Maker, MD
IRB Approval Number: EH14-187
Sponsor: Diabetic Retinopathy Clinical Research Network
Contact: Interested patients may contact Mira Shiloach at 847.657.1750 or mshiloach@northshore.org
Open to Enrollment: Yes